CORC

在结果中检索

CORC

浏览/检索结果: 共16条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
a phase 1 clinical trial of therapeutic vaccine t101 in chronic hepatitis b (chb) patients: a randomized, double-blind, placebo-controlled, single and multiple injections, dose escalation study 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Niu, Junqi;  Wang, Xiaomin;  Wang, Zhiming;  Wu, Min;  Gao, Dong
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
CHB肝纤维化患者血清C3、C4及IgG水平变化与病情程度的关系 期刊论文
解放军预防医学杂志, 2018, 卷号: 36, 期号: 8
作者:  李继红;  杭蕾;  孙世娟;  李长锋
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Increased numbers of CD5(+) CD19(+)CD1d(high)IL-10(+) Bregs, CD4(+)Foxp3(+) Tregs, CD4(+)CXCR5(+)Foxp3(+) follicular regulatory T (TFR) cells in CHB or CHC patients 期刊论文
JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 卷号: 12
作者:  Jiang, Yanfang;  Wang, Li;  Qiu, Jinpeng;  Yu, Lei;  Hu, Xiaoli
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
RESPONSE-GUIDED PEGINTERFERON ALFA-2a (PegIFN alfa-2a) THERAPY IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B (CHB) 会议论文
作者:  Niu, J.;  Xie, Y.;  Wan, M.;  Shi, G.;  Wang, H.
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir 期刊论文
HEPATOLOGY, 2013, 卷号: 58
作者:  Sun, Jian;  Yuan, Quan;  Xie, Qing;  Fan, Rong;  Tan, Deming
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Study of relationship between clinical efficacy and trough concentrations of ADV and TDF treatment of CHB 期刊论文
Journal of Gastroenterology and Hepatology, 2013
作者:  Sha X., Xin G., Song L., Yang W.
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir 会议论文
作者:  Cheng, Jun;  Yu, Yanyan;  Wang, Hao;  Xu, Min;  Shi, Guangfeng
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Study of relationship between clinical efficacy and trough concentrations of ADV and TDF treatment of CHB 期刊论文
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 卷号: 28
作者:  Sha, Xiujuan;  Xin, Guijie;  Song, Lisha;  Yang, Weimin
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
VIROLOGICAL BREAKTHROUGH AND GENOTYPIC RESISTANCE IN A RANDOMIZED, CONTROLLED STUDY ON TELBIVUDINE TREATMENT APPLYING ROADMAP CONCEPT IN CHB: W76 INTERIM ANALYSIS OF EFFORT STUDY 会议论文
作者:  Cheng, J.;  Yu, Y.;  Wang, H.;  Xu, M.;  Shi, G.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
BASELINE AND EARLY ON-TREATMENT CHARACTERISTICS IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) INFECTION ACHIEVING AN EARLY ON-TREATMENT RESPONSE TO PEGINTERFERON ALFA-2A: INTERIM RESULTS FROM THE RGT STUDY 会议论文
作者:  Hou, Jinlin;  Ma, Hong;  Sun, Jian;  Xie, Qing;  Xie, Yao
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace